• Brefeldin A in Cancer and Endothelial Research: Protocols &

  2026-05-18

  Brefeldin A (BFA) stands out as an ER stress inducer and vesicle transport inhibitor, enabling precise analysis of protein trafficking and apoptosis in cancer and endothelial injury models. This article translates recent biomarker advances and mechanistic findings into actionable workflows, troubleshooting guidance, and protocol enhancements for advanced cell biology research.

• Oligomycin A: Redefining Mitochondrial Bioenergetics in Canc

  2026-05-18

  Explore how Oligomycin A, a gold-standard mitochondrial ATP synthase inhibitor, is revolutionizing translational cancer metabolism research. We integrate mechanistic insights, recent immunometabolic evidence, and strategic protocol guidance to empower researchers targeting metabolic adaptation in tumors and tumor-associated macrophages (TAMs).

• RWJ 67657 and the Dual Control of p38α/β MAP Kinase in Cytok

  2026-05-17

  Explore how RWJ 67657 (JNJ-3026582) uniquely enables both inhibition and dephosphorylation of p38α/β MAP kinase, advancing the specificity and reproducibility of inflammatory disease research. This article offers a deep dive into the molecular mechanisms, practical assay protocols, and critical insights from recent structural biology.

• MHY1485: Potent mTOR Activator for Autophagy and Follicle St

  2026-05-16

  MHY1485 is a robust mTOR activator that inhibits autophagy by blocking autophagosome-lysosome fusion, enabling precise evaluation of mTOR signaling and cell survival pathways. This compound is validated for use in autophagy assays and ovarian follicle development research. APExBIO’s MHY1485 offers reliable performance for mechanistic studies in metabolism, oncology, and reproductive biology.

• Clathrin-Mediated Entry of GCRV104: Inhibitor Profiling Insi

  2026-05-15

  Wang et al. (2018) delineate the cellular entry mechanism of genotype III grass carp reovirus (GCRV104), demonstrating that infection proceeds via clathrin-mediated endocytosis and is independent of actin cytoskeleton disruption. Their systematic use of pharmacological inhibitors provides a refined framework for cytoskeletal organization studies in aquatic virology.

• Necrostatin-1: Applied RIP1 Kinase Inhibition in Necroptosis

  2026-05-15

  Necrostatin-1 enables precise dissection of necroptosis via selective RIP1 kinase inhibition, ideal for robust cell death pathway research and inflammatory disease models. This article decodes optimized workflows, troubleshooting, and translational insights for maximizing value from APExBIO’s Nec-1 in both in vitro and in vivo settings.

• N6-Methyl-dATP: Optimizing Epigenetic Fidelity in DNA Replic

  2026-05-14

  N6-Methyl-dATP enables precise investigation of DNA methylation’s impact on replication fidelity, enzyme specificity, and genomic stability. This article translates cutting-edge findings into actionable workflows, troubleshooting guidance, and comparative insights for epigenetic nucleotide analog use in advanced molecular biology research.

• Paeoniflorin Modulates Tmem176b+ Macrophages in Hepatic I/R

  2026-05-14

  This study demonstrates that paeoniflorin protects against hepatic ischemia-reperfusion (I/R) injury by shifting Tmem176b+ macrophages from a pro-inflammatory to a reparative phenotype. Single-cell RNA sequencing and functional depletion experiments reveal critical immunoregulatory mechanisms, highlighting new therapeutic targets for liver transplant complications.

• Carbapenemase Genes in CREC: Transmission Dynamics in Guangd

  2026-05-13

  This multicenter study reveals the high prevalence and efficient horizontal transfer of carbapenemase-encoding genes, particularly blaNDM-1, in carbapenem-resistant Enterobacter cloacae across teaching hospitals in Guangdong Province. The findings underscore the urgent need for enhanced molecular surveillance and provide methodological benchmarks for future antibiotic resistance research.

• WAY-100635: Advancing 5-HT1A Antagonist Research in Pain and

  2026-05-13

  This thought-leadership article explores the mechanistic, translational, and strategic value of WAY-100635, a potent and selective serotonin 5-HT1A receptor antagonist, for neuroscience researchers tackling the sensory and affective dimensions of pain. Bridging robust receptor pharmacology with emerging models of orofacial inflammatory pain and emotional comorbidity, we provide actionable guidance and protocol parameters for translational investigators. This piece moves beyond standard product overviews by integrating recent cross-domain research and highlighting untapped opportunities for WAY-100635 in multidimensional pain research.

• MHY1485 (SKU B5853): Precision mTOR Activation for Reproduci

  2026-05-12

  This article provides laboratory scientists with an evidence-driven guide to deploying MHY1485 (SKU B5853), a selective mTOR activator and autophagy inhibitor, for cell viability, proliferation, and autophagy studies. Drawing on validated protocols and peer-reviewed data, we address common workflow pitfalls and offer practical recommendations for reliable experimental outcomes. Researchers will find actionable insights for assay optimization, data interpretation, and vendor selection, anchored in real-world scenarios.

• Necrosulfonamide: Precision MLKL Inhibition in Necroptosis A

  2026-05-12

  Necrosulfonamide (NSA) enables selective, reproducible inhibition of MLKL-mediated necroptosis, crucial for dissecting cell death pathways in cancer and neurodegenerative disease models. This article translates advanced research into actionable workflows, troubleshooting strategies, and emerging opportunities for translational discovery.

• Reversible Cell Surface Mapping: Strategic Advances with Sul

  2026-05-11

  This article offers translational researchers mechanistic and strategic guidance for advanced cell surface protein and glycoRNA mapping, leveraging the unique chemistry of Sulfo-NHS-SS-Biotin (sulfosuccinimidyl-20(biotinamido)ethyl-1,3-dithiopropionate). By contextualizing the APExBIO Sulfo-NHS-SS-Biotin Kit within the evolving understanding of cell surface interactomes—especially the recent discovery of glycoRNA and cell surface RNA-binding protein nanoclusters—the piece bridges foundational biochemistry, protocol optimization, and next-generation experimental design for high-fidelity, reversible biotinylation.

• Liproxstatin-1: Ferroptosis Inhibitor Workflows & Protocol M

  2026-05-11

  Liproxstatin-1 empowers researchers with potent ferroptosis inhibition, enabling reproducible results in cell-based and in vivo models. This article delivers data-driven protocols, troubleshooting strategies, and translational insights to elevate ferroptosis research with APExBIO's trusted compound.

• Praeruptorin A: Mechanistic Leverage for Translational Break

  2026-05-10

  This thought-leadership article explores Praeruptorin A—a multi-targeted angular pyranocoumarin compound—as an advanced tool in translational research. Integrating mechanistic insights and protocol guidance, it addresses inflammation, cancer, and cardiomyopathy, and positions Praeruptorin A as a strategic asset for researchers moving from bench to bedside. The piece differentiates itself by connecting latest evidence, competitive context, and practical workflow optimizations, while referencing peer-reviewed findings and recent comprehensive reviews.

388 records 7/26 page Previous Next First page 上5页 678910 下5页 Last page